JP2014521925A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521925A5
JP2014521925A5 JP2014505668A JP2014505668A JP2014521925A5 JP 2014521925 A5 JP2014521925 A5 JP 2014521925A5 JP 2014505668 A JP2014505668 A JP 2014505668A JP 2014505668 A JP2014505668 A JP 2014505668A JP 2014521925 A5 JP2014521925 A5 JP 2014521925A5
Authority
JP
Japan
Prior art keywords
expression
disease
moment
biomarkers
calculating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014505668A
Other languages
English (en)
Japanese (ja)
Other versions
JP6163152B2 (ja
JP2014521925A (ja
Filing date
Publication date
Priority claimed from US13/252,080 external-priority patent/US20120271553A1/en
Application filed filed Critical
Publication of JP2014521925A publication Critical patent/JP2014521925A/ja
Publication of JP2014521925A5 publication Critical patent/JP2014521925A5/ja
Application granted granted Critical
Publication of JP6163152B2 publication Critical patent/JP6163152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014505668A 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現の積率による解析 Active JP6163152B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US61/478,224 2011-04-22
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,072 2011-10-03
US13/252,069 US20120270752A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,078 US20120269419A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,069 2011-10-03
US13/252,080 2011-10-03
US13/252,078 2011-10-03
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
PCT/EP2012/057387 WO2012143556A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments

Publications (3)

Publication Number Publication Date
JP2014521925A JP2014521925A (ja) 2014-08-28
JP2014521925A5 true JP2014521925A5 (enExample) 2015-06-18
JP6163152B2 JP6163152B2 (ja) 2017-07-12

Family

ID=47021377

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014505669A Active JP6063446B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現の積率による解析
JP2014505668A Active JP6163152B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現の積率による解析
JP2014505671A Active JP6063447B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現のクラスターによる解析
JP2014505670A Active JP6143743B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現のクラスターによる解析

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014505669A Active JP6063446B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現の積率による解析

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014505671A Active JP6063447B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現のクラスターによる解析
JP2014505670A Active JP6143743B2 (ja) 2011-04-22 2012-04-23 細胞におけるバイオマーカーの発現のクラスターによる解析

Country Status (8)

Country Link
US (5) US20120269418A1 (enExample)
EP (4) EP2700042B1 (enExample)
JP (4) JP6063446B2 (enExample)
BR (4) BR112013027123A2 (enExample)
CA (4) CA2833804A1 (enExample)
RU (3) RU2013145154A (enExample)
SG (4) SG194592A1 (enExample)
WO (4) WO2012143556A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
EP2929420B1 (en) * 2012-12-06 2022-03-02 Leica Microsystems CMS GmbH Systems and methods for split screen display of a biological specimen and for capturing records thereof
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) * 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
CA2916520A1 (en) * 2013-07-03 2015-01-08 Coyne Ip Holdings, Llc Methods for predicting responses to chemical or biologic substances
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
CN107430588B (zh) 2015-01-22 2021-12-31 斯坦福大学托管董事会 用于确定不同细胞亚群的比例的方法和系统
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
US10796130B2 (en) * 2015-12-22 2020-10-06 Nikon Corporation Image processing apparatus
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
US11042551B2 (en) * 2016-12-02 2021-06-22 Fair Isaac Corporation Fast automatic explanation of scored observations
US11436719B2 (en) 2017-02-16 2022-09-06 Kyoto University Cell evaluation method, cell evaluation device, and recording medium storing cell evaluation program
US10127696B2 (en) * 2017-03-22 2018-11-13 Sas Institute Inc. Computer system to generate scalable plots using clustering
WO2018201072A2 (en) 2017-04-28 2018-11-01 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
AU2018304381A1 (en) 2017-07-21 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
US10706328B2 (en) 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
US10971255B2 (en) * 2018-09-14 2021-04-06 Zasti Inc. Multimodal learning framework for analysis of clinical trials
US11101043B2 (en) 2018-09-24 2021-08-24 Zasti Inc. Hybrid analysis framework for prediction of outcomes in clinical trials
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
EP3886696A4 (en) * 2018-11-29 2022-08-24 SomaLogic Operating Co., Inc. PROCEDURE FOR DETERMINING DISEASE RISK USING A COMBINATION OF DOWNSAMPLING OF CLASS IMBALANCED DATASETS WITH SURVIVAL ANALYSIS
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
JP7368679B2 (ja) * 2021-09-01 2023-10-25 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
IT202200001817A1 (it) 2022-02-02 2023-08-02 Aizoon S R L Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico
IT202200005861A1 (it) 2022-03-24 2023-09-24 Aizoon S R L Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico
AU2023208071A1 (en) 2022-07-25 2024-02-08 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
CA2440703A1 (en) * 2001-01-24 2002-08-01 Protein Design Labs, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
WO2004013658A2 (en) * 2002-07-30 2004-02-12 Deutsches Krebsforschungszentrum Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
WO2006113747A2 (en) * 2005-04-19 2006-10-26 Prediction Sciences Llc Diagnostic markers of breast cancer treatment and progression and methods of use thereof
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
US8114615B2 (en) * 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
CA2678919A1 (en) * 2007-03-27 2008-10-02 Ranit Aharonov Gene expression signature for classification of cancers
EP2143043A4 (en) * 2007-05-07 2011-01-12 Ge Healthcare Bio Sciences SYSTEM AND METHOD FOR THE AUTOMATED ANALYSIS OF CELLULAR ASSAYS AND TISSUE
ES2374686T3 (es) * 2007-05-14 2012-02-21 Historx, Inc. Separación en compartimentos por caracterización de píxel usando agrupamiento de datos de imágenes.
WO2009108215A1 (en) * 2007-09-06 2009-09-03 Aviaradx, Inc. Tumor grading and cancer prognosis
CA3074969C (en) * 2008-07-25 2023-06-13 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8320655B2 (en) * 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Similar Documents

Publication Publication Date Title
JP2014521925A5 (enExample)
JP2014517954A5 (enExample)
Ferlizza et al. The roadmap of colorectal cancer screening
Justino et al. Critical overview on the application of sensors and biosensors for clinical analysis
Schraml et al. Imaging of HCC—current state of the art
HK1201180A1 (en) Method and system for analyzing biological specimens by spectral imaging
FI3312749T3 (fi) Menetelmiä ja laitteita eturauhassyövän riskin ja eturauhasen tilavuuden ennustamiseen
WO2012143556A3 (en) Analyzing the expression of biomarkers in cells with moments
Komuta Histological heterogeneity of primary liver cancers: clinical relevance, diagnostic pitfalls and the pathologist’s role
JP7563764B2 (ja) 癌関連ｔｃｒレパートリの抗原非依存的デノボ予測のコンピュータシステム及び方法
Haffner et al. Framework for the pathology workup of metastatic castration-resistant prostate cancer biopsies
Nair et al. Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review
Brannon et al. “N of 1” case reports in the era of whole-genome sequencing
Galeș et al. Cancer Screening: Present recommendations, the development of Multi-Cancer Early Development tests, and the prospect of universal cancer screening
National Cancer Institute Clinical Proteomic Tumor Analysis Consortium The Clinical Proteomic Tumor Analysis Consortium Lung Adenocarcinoma Collection (CPTAC-LUAD)
JP2010526995A5 (enExample)
Peluso et al. Right ventricular geometry and function in pulmonary hypertension: Non-invasive evaluation
WO2012153964A3 (ko) 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법
CN113039551A (zh) 分析细胞的方法、细胞分析设备与计算机可读存储介质
WO2014050129A1 (ja) 画像処理装置および方法並びにプログラム
Lopes et al. Advances towards gastric cancer screening: Novel devices and biomarkers
Grinstead et al. Slice-accelerated inversion recovery T1 mapping
Angeli et al. Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease
EP2998408A4 (en) Method for obtaining epigenetic cell information, method for determining cell characteristics, method for assessing drug sensitivity or selecting drug or immunotherapeutic agent variety, disease diagnosis method, self-replicating vector, assay kit, and analysis device
RU2013145829A (ru) Анализ экспрессии биомаркеров в клетках с помощью моментов распределения